NORMAX STORY
WEBSITE for Normax Biomed Limited (NRMX)
Normax Extreme Social Impact (ESI) Blog
FACT: EXTREME COST of COVID-19, PATHOGENS & PANDEMIC RISK
WHO. 04 JAN 2023: "XBB.1.5 Most Transmissible Subvariant Yet."
BIOSECURITY: Inevitable Evolution of COVID and New Pathogens
EVERY 20 SECONDS in 2021... Somebody DIED of Tuberculosis (WHO)
The MISSION of Normax (1:00)
Normax IN-THE-NEWS
Normax PRESS ROOM
Normax on TWITTER
Normax on THE ROAD TO IRELAND with Pharma's Almanac (4:26)
Normax SUMMARY
Normax FAQ
Normax at VALIDATE NETWORK
mRNA UCV Consortium by Normax
Normax SOCIAL VALUE (ESG) for Stakeholders and Investors
PURPOSE, CULTURE & VALUES of Normax
LOW-COST mRNA VACCINES for COVID, TB, HIV... by Normax
VACCINE EQUITY. mRNA Vaccines by Normax. Save a Life for $4.00
EDITORIAL. European Pharmaceutical Manufacturer. The time for mRNA vaccine equality across the globe by Peter Jensen
NO PANDEMICS by Normax. PATHOGENS and PANDEMICS. A Deadly Cost and Risk For All.
GOAL 2050 by Normax. End transmission of TB and HIV by 2050.
THE LANCET. 19.8 million deaths from COVID-19 averted during the first year of COVID-19 vaccination
REPORT. COVID-19 Vaccination program in U.S. saved 3.2 million lives and U.S. $1.15 trillion in 2 years
QUICK FACTS. mRNA Vaccine Technology & mRNA in Nature
OPEN ACCESS DATA. Scientific Reference & Review Digest
MARKET REPORTS. Long-Term Market Outlook for mRNA Vaccines and Therapeutics and SARS-CoV-2 Vaccines for Endemic COVID-19
MARKET DATA. Leading mRNA Biomedical & Biotech Companies
MARKET DATA. $110-$130 per Covid Vaccine by Moderna & Pfizer
MARKET DATA. Covid-19 mRNA Vaccines Lead Drug Sales 2021/22
BNTX Q3 2022 EXAMPLE: "€13.4 billion cash and cash equivalents plus total trade receivables of €7.3 billion"
€300,000,000 CAPITAL COMMITMENT secured by Normax
Normax Story FOR INVESTORS in a few minutes...
Linkedin: Peter A. Jensen, CEO & Chairman, Normax Biomed Ltd.
CONTACT US
